Brief: Amphastar Announces Approval For Glucagon For Injection Kit, 1Mg
29/12/2020 11:03
Dec 29 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O :
* AMPHASTAR ANNOUNCES APPROVAL FOR GLUCAGON FOR INJECTION
KIT, 1MG
* AMPHASTAR PHARMACEUTICALS - PLANS TO LAUNCH THIS GLUCAGON
FOR
INJECTION EMERGENCY KIT, WHICH IT PREVIOUSLY REFERRED TO AS
AMP-001, WITHIN TWO MONTHS
Source text for Eikon: ID:nGNX4PdsDp
Further company coverage: AMPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing